These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10828315)

  • 1. Current status and recent developments in anthracenone antipsoriatics.
    Müller K
    Curr Pharm Des; 2000 Jun; 6(9):901-18. PubMed ID: 10828315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
    Müller K
    Biochem Pharmacol; 1997 May; 53(9):1215-21. PubMed ID: 9214681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
    Wiegrebe W; Müller K
    Skin Pharmacol; 1995; 8(1-2):1-24. PubMed ID: 7786521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
    Müller K; Reindl H; Breu K
    J Med Chem; 2001 Mar; 44(5):814-21. PubMed ID: 11262091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
    Müller K; Leukel P; Ziereis K; Gawlik I
    J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974; 249(2):179-89. PubMed ID: 4418435
    [No Abstract]   [Full Text] [Related]  

  • 7. 10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis.
    Müller K; Breu K; Reindl H
    Eur J Med Chem; 2001 Feb; 36(2):179-84. PubMed ID: 11311748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
    Müller K; Prinz H; Gawlik I; Ziereis K; Huang HS
    J Med Chem; 1997 Nov; 40(23):3773-80. PubMed ID: 9371243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure specificity of the antipsoriatic anthrones.
    Krebs A; Schaltegger H; Schaltegger A
    Br J Dermatol; 1981 Aug; 105 Suppl 20():6-11. PubMed ID: 7284267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.
    Müller K; Gürster D; Piwek S; Wiegrebe W
    J Med Chem; 1993 Dec; 36(25):4099-107. PubMed ID: 8258834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
    Müller K; Huang HS; Wiegrebe W
    J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
    Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
    J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects.
    Müller K
    Gen Pharmacol; 1996 Dec; 27(8):1325-35. PubMed ID: 9304402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthralin cream as short contact therapy for psoriasis.
    Miller AC
    Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A very promising treatment method in psoriasis. Short-term anthralin therapy].
    Kunze J; Petres J
    Fortschr Med; 1981 May; 99(20):761-4. PubMed ID: 7262756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.